Micromet's Acquisition

Micromet was acquired by Omega Advisors on December 06, 2004.

Micromet is focused on biological products for the treatment and control of cancer, inflammatory and autoimmune diseases. Using its antibody technology platforms, Micromet strives to create novel drug…

Articles about Micromet's Acquisition: